ASN
MRNA icon

Advisory Services Network’s Moderna MRNA Stock Holding History

Advisory Services Network’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$402K Buy
7,908
+3,321
+72% +$155K 0.01% 1409
2025
Q4 		$135K Sell
4,587
-6,076
-57% -$165K ﹤0.01% 1736
2025
Q3 		$275K Sell
10,663
-438
-4% -$12.2K ﹤0.01% 1516
2025
Q2 		$328K Buy
11,101
+4,789
+76% +$126K 0.01% 1362
2025
Q1 		$179K Sell
6,312
-13,291
-68% -$472K ﹤0.01% 1530
2024
Q4 		$815K Buy
19,603
+16,555
+543% +$791K 0.02% 833
2024
Q3 		$362K Hold
3,048
– – 0.01% 1123
2024
Q2 		$362K Sell
3,048
-1,302
-30% -$165K 0.01% 1123
2024
Q1 		$464K Sell
4,350
-8,365
-66% -$843K 0.01% 993
2023
Q4 		$1.26M Buy
12,715
+5,667
+80% +$477K 0.03% 552
2023
Q3 		$728K Buy
7,048
+2,600
+58% +$290K 0.02% 755
2023
Q2 		$540K Buy
4,448
+73
+2% +$9.74K 0.01% 880
2023
Q1 		$672K Sell
4,375
-1,456
-25% -$240K 0.02% 771
2022
Q4 		$1.05M Buy
5,831
+1,098
+23% +$180K 0.03% 585
2022
Q3 		$560K Buy
4,733
+209
+5% +$31.7K 0.02% 750
2022
Q2 		$646K Sell
4,524
-78
-2% -$11.1K 0.02% 721
2022
Q1 		$793K Buy
4,602
+990
+27% +$167K 0.02% 708
2021
Q4 		$918K Sell
3,612
-2,175
-38% -$636K 0.03% 657
2021
Q3 		$2.23M Buy
5,787
+3,230
+126% +$1.19M 0.07% 356
2021
Q2 		$601K Sell
2,557
-3,467
-58% -$620K 0.02% 803
2021
Q1 		$789K Buy
6,024
+3,692
+158% +$535K 0.03% 647
2020
Q4 		$244K Buy
2,332
+302
+15% +$30.6K 0.01% 988
2020
Q3 		$144K Buy
+2,030
New +$142K 0.01% 1100
2020
Q2 		– Sell
-7,608
Closed -$228K – 2089
2020
Q1 		$228K Buy
+7,608
New +$175K 0.01% 767

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisory Services Network's MRNA Position: Q1 2026 in Review

Advisory Services Network increased its Moderna (MRNA) stake by 72% in Q1 2026, buying an estimated $155K and bringing the position to 7,908 shares worth $402K. The position accounts for 0.01% of the portfolio, ranked #1409.

Advisory Services Network first reported a position in MRNA in Q1 2020 and has held it in 24 quarters since. The position peaked at $2.23M in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Advisory Services Network held 7,908 shares of Moderna worth $402K as of Q1 2026.
  • Advisory Services Network bought 3,321 Moderna shares in Q1 2026, an estimated $155K.
  • Moderna made up 0.01% of Advisory Services Network's portfolio in Q1 2026, its #1409 holding.
  • Advisory Services Network first reported a position in Moderna in Q1 2020 and has held it in 24 quarters since.
  • Advisory Services Network's Moderna position peaked at $2.23M in Q3 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.